Autoimmune hepatitis vs. Pregnancy by Adamczyk-Gruszka, Olga et al.
Adamczyk-Gruszka Olga, Lewandowska-Andruszuk Izabela, Gruszka Jakub, Komar-Gruszka Karolina. Autoimmune hepatitis vs.
Pregnancy.  Journal  of  Education,  Health  and  Sport.  2017;7(7):479-486.  eISSN  2391-8306.  DOI
http://dx.doi.org/10.5281/zenodo.835146
http://ojs.ukw.edu.pl/index.php/johs/article/view/464  8  
The journal has had 7 points in Ministry of Science and Higher Education parametric evaluation. Part B item 1223 (26.01.2017).
1223 Journal of Education, Health and Sport eISSN 2391-8306 7
© The Authors 2017;
This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland
Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.
This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial
use, distribution and reproduction in any medium, provided the work is properly cited.
The authors declare that there is no conflict of interests regarding the publication of this paper.
Received: 01.07.2017. Revised: 02.07.2017. Accepted: 26.07.2017.
Autoimmune hepatitis vs. Pregnancy
Authors: Olga Adamczyk-Gruszka1, Izabela Lewandowska-Andruszuk2
Jakub Gruszka3, Karolina Komar-Gruszka4 
1Olga Adamczyk–Gruszka PhD: Departament of Prophylaxis In Gynecology and
Obstetrics, Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland,
e-mail: kasia.kielce@poczta.fm, mobile phone: 605233038
2Izabela Lewandowska-Andruszuk Departament of Perinatology and Obstetric-
Gynecological Nursing , Faculty of Health Sciences, Jan Kochanowski University,
Kielce, Poland
3Jakub Gruszka: doctor Provincial Integrated Hospital in Kielce, Poland
4Karolina Komar-Gruszka: doctor Provincial Integrated Hospital in Kielce, Poland
Summary
Introduction
Autoimmune hepatitis (AIH) is a disease of unknown etiology. In pregnancy, it may
have mild  clinical  course  as  well  as  can  lead  to  liver  failure,  or  exacerbation  of  clinical
symptoms.  In  pregnant  women  the  severity  of  symptoms  is  often  observed  between  the
second and third trimester, and in the puerperium. The disease is marked by enhanced activity
of  Th  lymphocytes,  which  hepatocytes  recognize  as  foreign  antigens.  This  results  in
interleukin production activating B lymphocytes, and the production of specific antibodies
attacking and destroying the hepatocytes.
Case report
A 35-year old patient, CII PII, 7 Hbd, with autoimmune hepatitis reported for a check-
up. Her first pregnancy was 18 years ago, without history of underlying disease, carried to
term without complications. The woman gave birth to a baby-son weighing 3,280g, 10 points
Apgar. The delivery was spontaneous and uneventful. The patient got pregnant after an 18-
year break. When she twice-tested positively for pregnancy, the treatment with azathioprine
was switched to prednisolone.
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Over the  pregnancy the patient  was hospitalized  4 times,  in  25,  29,  35,  and 37 week of
gestation due to a threat of preterm delivery,  and pregnancy-related cholestasis  associated
with AIH.
In 37 week of gestation, delivery was induced, and she gave birth to a healthy male, weighing
2,650 g,  body height  of  49  cm,  10 points  Apgar  scale.  The liver  function  improved and
stabilized  after  the  delivery.  Treatment  with  prednisolone  has  been  continued,  and  the
patient’s condition is still controlled.
Pregnant  patients  with  autoimmune  hepatitis  often  experience  exacerbation  of  the
disease, especially in the third trimester, and in the postpartum period. This case shows that
with proper care it is possible to continue and terminate pregnancy safely for the mother and
her newly born baby.
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Introduction
Autoimmune  hepatitis  (AIH)  is  a  chronic  disease  of  unknown  etiology,  with  an
incidence of 11-17 per 100,000 cases [3.6]. Approximately 70% of the patients are women.
Clinical manifestations depend on the dynamics of inflammatory process. In the course of
disease, Th lymphocytes are activated, and hepatocytes recognize them as foreign antigens.
Th  lymphocytes  produce  interleukins  that  activate  B  lymphocytes  to  produce  specific
antibodies  that  attack  and  damage  the  hepatocytes.  As  B  lymphocytes  increase,
hypergammaglobulinemia  develops,  which  can  lead  to  acute  or  chronic  hepatitis  [9,14].
Patients have abnormal laboratory results, and develop clinical symptoms such as fatigue,
weakness, drowsiness, abdominal pains, sometimes anorexia [14,19].
In the literature, there are over 200 pregnancies reported in women suffering from AIH [1]. In
case of women suffering from AIH, pregnancy poses a problem for both the pregnant and the
developing fetus. Complications occur in 21% pregnant women, and in 90% women after
termination  of  pregnancy [5,10,18,21].  The  risk  of  miscarriage  increases  to  24%,  and of
preterm delivery  to  17% [4].  In  women  with  AIH,  the  severity  of  liver  disease  and  its
biochemical parameters are often exacerbated [26]. Impaired hormonal metabolism due to
glycocorticosteroid treatment can result in menstrual disorders and eventually infertility in
women. [13,14]. Most young patients respond positively to standard treatment.
Case report
In  2016  a  35-year  old  patient  with  a  positive  pregnancy  test  was  seen  in  the
gynecological office to confirm pregnancy. Her past history revealed autoimmune hepatitis
diagnosed in 2008. The patient was treated with azathioprine and prednisone. The patient was
not  qualified  for  liver  transplantation  as  her  biochemical  parameters  of  liver  tests  were
normal.
Eighteen years earlier she gave birth in 38 Hbd. to a male, weighing 3,280g / 10 points Apgar
scale, uneventful spontaneous delivery.
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USG scan taken in 7 Hbd.: CRL-12 mm, single embryo, live, visualized in the uterine
cavity. Gall bladder normal, no signs of chorionic detachment. Pharmacological treatment was
modified by a specialist in infectious diseases, prednisone was started instead of azathioprine.
Throughout the pregnancy, the patient was monitored by a specialist in infectious diseases,
obstetrician and gynecologist.
The patient was hospitalized four times in the Department of Pregnancy Pathology in
25,  29,  35  and  37  Hbd.  for  autoimmune  hepatitis,  pregnancy-associated  cholestasis,  and
threatening preterm delivery.
The patient was first hospitalized in the 25th week of gestation. She reported at the
Clinic of Pregnancy Pathology for skin pruritus and abdominal pain.  USG scan found no
abnormalities, fetal biometry was normal for the gestational age, laboratory tests found no
significant deterioration in the liver function parameters. After a 3-day stay in hospital, the
pregnant woman was discharged home. She was prescribed Prednisone, Ursopol, Hepa Merz,
and Essentiale Forte.
In  the  29th week  of  pregnancy,  the  patient  was  again  hospitalized  for  intense
cholestasis  in  the  form of  generalized  skin  itching,  and  threatening premature  labor.  The
patient  was  given  Hydroxyzine,  orally,  and  Lutein  vaginally.  USG  scan  showed  no
abnormalities in the fetal development. Cardiotocography was normal. Laboratory test found
worsened parameters of the liver function, concentrations of aminotransferases and bile acids
were  increased.  After  a  five-day  hospitalization,  the  pregnant  woman  (fetus  live)  was
discharged home.
Another  hospitalization  was  in  the  35th week  of  gestation:  more  than  doubled
aminotransferase concentrations, and increased bile acid concentrations up to 35 umol / l (lab
tests taken by the patient). During a three-day hospitalization on the ward, the parameters
normalized.  The  patient  was  discharged  home  with  live  pregnancy,  USG  and
cardiotocography normal.
During the entire duration of pregnancy, periodic deterioration in the liver function parameters
was observed in laboratory tests. (Table 1).




Normal range 25Hbd 29Hbd 35Hbd
ALP 35-125 U/L 164 U/L
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ALT 5-50 U/L 101 U/L 136 U/L 104 U/L
AST 5-50 U/L 52 U/L 70 U/L 58 U/L
Total protein 6.0-8.0 g/dl 6.40 g/dl 6.7 g/dl 7.0 g/dl
Bilirubin 0.10-1.30 mg/dl 0.40 mg/dl 0.47 mg/dl 0.63 mg/dl
CRP 0.1-5.0 mg/l 2.19 mg/l
APTT 26.0-40.0 sek 24.5 sek 23.1 sek 22.4 sek
PT 9.7-14.5 sek 10.5 sek 10.3 sek 9.8 sek
INR PT 70-130 % 109 % 104 % 110 %
INR 0.8-1.2 0.9 0.9 0.8
TT 15.0-25.0 sek 15.0 sek 14.6 sek 15.3 sek
GGTP 10-40 U/L 50 U/L 42 U/L
Glucose 65-100 mg/dl 71 mg/dl
Creatinine 0.70-1.30 mg/dl 0.70 mg/dl 0.71 mg/dl 0.69 mg/dl
Urea 20-45mg/dl 18 mg/dl 25 mg/dl
Uric acid 3.40-7.00mg/dl 4.40 mg/dl 4.6 mg/dl 5.8 mg/dl
Bile acids 0-15.0 umol/l 10.9 umol/l 34.4 umol/l 29.6 umol/l
LDH 120-230 U/L 187 U/L 171 U/L 190 U/L
Urinanalysis NAD NAD NAD NAD
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HGB 12.0-15.6 g/dl 13.0 g/dl 13.1 g/dl 14.8 g/dl
HCT 35.0-46.0 % 37.6 % 37.8 % 42.3 %
RBC 3.6-5.2 M/ul 4.13 M/ul 4.13 M/ul 4.68 M/ul
WBC 4.1-10.9 K/ul 7.35 K/ul 9.9 K/ul 9.88 K/ul
PLT 140-440 K/ul 164 K/ul 170 K/ul 196 K/ul
Na 137-146mEq/l 134 mEq/l 138 mEq/l 137 mEq/l
K 3.5-5.2 mEq/l 3.8 mEq/l 3.8 mEq/l 4.2 mEq/l
In the 37th week of gestation, the patient was admitted to the ward to terminate her
pregnancy. On admission she presented with intense skin pruritus and slow fetal movements,
liver  parameters  deteriorated.  The  patient  was  transferred  to  the  delivery  room,  Mizodel
vaginal pessary was inserted to induce labor.  When the labor commenced, at  4-cm cervix
dilation,  epidural  anesthesia  was  administered.  The  patient  delivered  naturally,  a  healthy
newborn male was born, 2,650 g, 49 cm, Apgar score of 10 points in the first, third and fifth
minute, umbilical cord blood pH 7.419. The postpartum period uneventful. The patient was
discharged home on 7 day.
Currently,  the  patient  is  followed-up  in  the  Clinic  of  Infectious  Diseases,  and
Prednisone continued. There has been no evidence of relapse of AIH symptoms. Since the
liver function stabilized, the patient does not require liver transplantation.
Discussion
Diagnosis of autoimmune hepatitis is not easy, and there is no a single diagnostic test
to confirm the disease. Increased values of sMA, ANA, anti-LKM-1, anti-sLA, Lp, p-ANCA,
anti-LC1, anti-AsGpR, and hypergammaglobulinemia are the most common parameters that
may indicate the condition [15, 17, 18].
There  are  three  types  of  autoimmune  hepatitis  distinguished  on  the  basis  of  the
presence of serum antibodies [16, 23]:
• type 1 – positive AsMA (anti-smooth muscle antibody) or ANA (anti-nuclear antibody),
• type 2 – positive anti-LKM-1 (anti-liver kidney microsomes) ,
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• type 3 – positive anti-sLA (anti-soluble liver antibody), or antibodies that react with hepatic
and pancreatic antigens (Lp).
Differential  diagnosis  should  exclude  other  metabolic  and viral  hepatitis  [6,17,20].
Autoimmune hepatitis is diagnosed on the basis of the criteria established by the International
Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
[7,11,22]. Diagnostic imaging uses ultrasound and CT scan. Liver biopsy is also performed,
but  it  is  not  a  pathognomonic  study.  The image does  not  differentiate  AIH from chronic
hepatitis [22].
The recommended treatment uses corticosteroids (Prednisone) at a dose of 40-60 mg
or 1 mg / kg inducing remission of the symptoms [12,24,28].
In the world literature, about 200 cases of pregnancy were reported in women with
AIH, - some complicated by cirrhosis [1]. According to the literature, 20% pregnant women
suffering from AIH experience exacerbated symptoms at various periods of their pregnancies.
In the postpartum period and laying-in complications are observed in 90% cases [5,10,15,18].
Complications  may  cause  decompensation  of  the  liver  function,  the  need  for  liver
transplantation,  or  death  of  the  patient  [17].  Fortunately,  most  women are  controlled  and
immunosuppressed.
In a study by Westbrook et al., 81 pregnant women with AIH were examined. Hepatic
cirrhosis  in the mother was associated with a higher risk of serious complications (death,
transplantation within up to 12 months after pregnancy, or liver decompensation within up to
3 months after pregnancy). In the above presented case, a temporary deterioration of the liver
function during pregnancy with later stabilization of the function was observed.
The remission of autoimmune hepatitis during pregnancy was described several times
in the literature [5]. It is currently believed to be due to increased levels of estrogens that
inhibit the immune activity, and progesterone which affects the anti-inflammatory properties
of Th2 helper lymphocytes [25,27]. Immune mechanisms developing during pregnancy also
include increased number of T regulatory lymphocytes responsible for the immune tolerance
of the fetus [2,3].
Unfortunately, after the termination of pregnancy those mechanisms disappear, which
is  why AIH exacerbation is  observed afterwards.  In the above presented case,  permanent
deterioration in the liver function was not observed during or after the completion of both
pregnancies, and over several years of follow-up period.
Another important problem raised in the literature is the effect of pregnancy on portal
hypertension  [8.20].  Because  of  altered  visceral  flow  and  anatomical  conditions  in  the
abdomen associated with the growing uterus, the risk of esophageal varices is significantly
increased [8, 20].
According to literature data, the percentage of live births among pregnant women with
AIH is 71-86% [5,10,15,23], and preterm births occur in up to 20% cases [17]. In a study by
Westbrook  et  al.,  pre-pregnancy  liver  cirrhosis  in  the  mother  was  associated  with  a
statistically lower live birth rate and a higher rate of prematurity than in AIH women without
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advanced  cirrhosis.  Neonates  of  the  mothers  with  cirrhosis  or  exacerbated  symptoms  in
pregnancy also required statistically more frequent admission to neonatal intensive care units.
In the afore mentioned case, both pregnancies resulted in the birth of two healthy newborn
males (in 37 and 38 Hbd). The babies were born with normal birth weight, none of them
required intensive neonatal care.
The presented case shows that a successful  outcome can be expected for both the
mother and the fetus provided pregnant women with impaired liver function in the course of
AIH  receive  proper  gynecological,  obstetric  and  hepatological  care.  Improvement  and
stabilization of the liver function were observed after pregnancy and persisted over a 10-year
follow-up period. Currently they allow for conservative treatment of the patient who does not
require liver transplantation today.
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